Search Options Stock News and Analysis from Schaeffer's

Pharma Stock Signal Has Never Been Wrong

https://www.schaeffersresearch.com/content/analysis/2020/10/28/pharma-stock-signal-has-never-been-wrong

10/28/2020 3:01 PM

The shares of Bristol-Myers Squibb Co (NYSE:BMY) are down 1.7% at $57.73 at last check. And while the pharmaceutical name carries a 10% year-to-date deficit, investors should not turn their backs on ...

MYOK Swings Higher on Buyout Buzz

https://www.schaeffersresearch.com/content/news/2020/10/05/myok-swings-higher-on-buyout-buzz

10/5/2020 11:39 AM

Bristol-Meyers Squibb (BMY) announced this morning that it was buying heart drug developer MyoKardia Inc (NASDAQ:MYOK) for $13 billion, or $225 per share in cash, as a way to boost its portfolio of h...

Nektar Therapeutics Options Pop as Stock Soars

https://www.schaeffersresearch.com/content/options/2020/01/10/nektar-therapeutics-options-pop-as-stock-soars

1/10/2020 1:34 PM

The shares of Nektar Therapeutics (NASDAQ:NKTR) are pacing for their biggest one-day jump in almost two years after the firm amended its collaboration agreement with Bristol-Myers Squibb (BMY). The t...

Beware This Pharmaceutical Stock Next Month

https://www.schaeffersresearch.com/content/analysis/2019/12/31/beware-this-pharma-stock-next-month

12/31/2019 10:34 AM

The U.S. stock market is set to wrap up the year with big monthly and annual gains, with the S&P 500 Index (SPX) pacing toward returns of 2.6% for December and 28.6% for 2019. Looking ahead to 2020, b...

Apple Leads Tech Giants Into Another Thick Earnings Slate

https://www.schaeffersresearch.com/content/news/2019/10/24/apple-leads-tech-giants-into-another-thick-earnings-slate

10/24/2019 11:50 AM

Traders are gearing up for another busy few days of earnings, with Apple's (AAPL) quarterly report due right in the middle of the week. Fellow tech concerns Alphabet (GOOGL) and Facebook (FB) are als...

PEOPLE ALSO SEARCH FOR